4.6 Article

Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia Type 3: a Randomized, Double-Blind, Sham-Controlled Trial

Roderick P. P. W. M. Maas et al.

Summary: The study found that a two-week daily cerebellar tDCS treatment did not have a significant effect on the severity and cerebellar-M1 connectivity of spinocerebellar ataxia type 3 (SCA3) patients. While some patients showed sustained symptom reduction, overall treatment effects varied between individuals.

NEUROTHERAPEUTICS (2022)

Review Clinical Neurology

Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations

Santiago Perez-Lloret et al.

Summary: This study evaluated the clinimetric properties of various ataxia rating scales and functional tests, identifying recommended scales and tests for patients with major hereditary ataxias and other cerebellar disorders. However, the main limitations of these instruments include limited assessment of patients on the severe end of the spectrum and children. Further research is needed in these populations.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

Inverse associations between cerebellar inhibition and motor impairment in spinocerebellar ataxia type 3

Roderick P. P. W. M. Maas et al.

Summary: Reduced levels of cerebellar inhibition (CBI) were found to be inversely associated with ataxia severity and manual dexterity in patients with spinocerebellar ataxia type 3 (SCA3). Additionally, CBI was significantly correlated with Scale for the Assessment and Rating of Ataxia (SARA) scores and nine-hole peg test performance in this cohort.

BRAIN STIMULATION (2021)

Article Clinical Neurology

Exploring the clinical meaningfulness of the Scale for the Assessment and Rating of Ataxia: A comparison of patient and physician perspectives at the item level

Roderick P. P. W. M. Maas et al.

Summary: The study found significant discrepancies between patients and physicians in the ratings of SARA items. On average, patients were overestimated by 3.1 ± 2.1 SARA points. Underestimation occurred less frequently, but was relatively common in stance and fast alternating hand movements. The majority of patients considered gait to be the most valuable SARA item, while the remaining 25% chose stance.

PARKINSONISM & RELATED DISORDERS (2021)

Article Clinical Neurology

Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3

Jennifer Faber et al.

Summary: The study aimed to quantify regional brain volumes and cervical spinal cord areas in spinocerebellar ataxia type 3 patients using MRI, revealing that tissue loss in the brain and spinal cord starts before ataxia onset in early-stage patients. Pontine volume is identified as a potential imaging biomarker candidate for intervention trials aiming to slow the progression of the disease.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

Development and Validation of a Patient-Reported Outcome Measure of Ataxia

Jeremy D. Schmahmann et al.

Summary: The study developed a Patient-Reported Outcome Measure of Ataxia through online surveys completed by ataxia patients, scored on a 0-4 Likert scale. The measurement showed high internal consistency and reliability, and was sensitive to ataxia severity. It was significantly associated with measures of ataxia, quality of life, and mental health.

MOVEMENT DISORDERS (2021)

Article Genetics & Heredity

Neurologic outcomes in Friedreich ataxia: Study of a single-site cohort

Massimo Pandolfo

NEUROLOGY-GENETICS (2020)

Article Medicine, General & Internal

Spinocerebellar ataxia

Thomas Klockgether et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Article Clinical Neurology

Structural signature of SCA3: From presymptomatic to late disease stages

Thiago Junqueira Ribeiro Rezende et al.

ANNALS OF NEUROLOGY (2018)

Article Genetics & Heredity

The progression rate of spinocerebellar ataxia type 2 changes with stage of disease

Thais Lampert Monte et al.

ORPHANET JOURNAL OF RARE DISEASES (2018)

Article Neurosciences

Construct Validity and Reliability of the SARA Gait and Posture Sub-scale in Early Onset Ataxia

Tjitske F. Lawerman et al.

FRONTIERS IN HUMAN NEUROSCIENCE (2017)

Review Clinical Neurology

The preclinical stage of spinocerebellar ataxias

Roderick P. P. W. M. Maas et al.

NEUROLOGY (2015)

Article Clinical Neurology

A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease

Jonas Alex Morales Saute et al.

MOVEMENT DISORDERS (2014)

Review Public, Environmental & Occupational Health

The Global Epidemiology of Hereditary Ataxia and Spastic Paraplegia: A Systematic Review of Prevalence Studies

Luis Ruano et al.

NEUROEPIDEMIOLOGY (2014)

Article Clinical Neurology

Factors Influencing Disease Progression in Autosomal Dominant Cerebellar Ataxia and Spastic Paraplegia

Sophie Tezenas du Montcel et al.

ARCHIVES OF NEUROLOGY (2012)

Article Clinical Neurology

Responsiveness of different rating instruments in spinocerebellar ataxia patients

T. Schmitz-Huebsch et al.

NEUROLOGY (2010)

Article Clinical Neurology

New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado–Joseph disease)

Udo Rüb et al.

CURRENT OPINION IN NEUROLOGY (2009)

Article Genetics & Heredity

Survival estimates for patients with Machado-Joseph disease (SCA3)

C. Kieling et al.

CLINICAL GENETICS (2007)

Article Clinical Neurology

Scale for the assessment and rating of ataxia -: Development of a new clinical scale

T. Schmitz-Huebsch et al.

NEUROLOGY (2006)